Neelim للاستشارات الصحية
Neelim
Consultant title · oral assessment

Consultant Pulmonology oral assessment prep

14 panel-style scenarios with model answers structured in the three graded domains - knowledge, management, and ethics & communication.

Pass / fail panel14 scenarios
AED 699one-time
About 68% of one exam fee
Request this question bank

Tell us your authority and we send the bank for that exam, usually the same day.

What is riding on this exam

~AED 1,030
DHA exam fee, per attempt
Paid again on every re-sit. Other regulators' fees are in the table below.
3
UAE attempts - in total
Shared across DHA, DOH, MOHAP and SHA, not three each. Saudi, Qatar, Oman and Kuwait rules are in the FAQ.
Pass / fail
Panel decision
Judged by the panel, not a percentage. Formats differ by authority.

One failed attempt costs you the fee again, plus months of delay on your licence, your visa and your start date. This pack costs about 68% of one exam fee.

Every regulator: format, pass marks and fees for all GCC licensing exams, each from the regulator's own documents.

Try a scenario from this pack

An original scenario, written the way a panel would put it to you.

Scenario 1Obstructive Lung Disease / Critical Care

You are the on-call consultant asked to review a 28-year-old woman in the emergency department of a private hospital in Dubai. She has had asthma since childhood, was intubated once three years ago, and has used four salbutamol inhalers in the past month with no controller therapy. She is agitated, unable to complete sentences, respiratory rate 34, heart rate 138, oxygen saturation 89% on 6 L/min, with a silent chest on auscultation; the first arterial blood gas shows pH 7.28, PaCO2 6.9 kPa, PaO2 7.4 kPa, lactate 4.1. How would you assess and manage this patient?

What the panel is assessing

The panel is testing whether you can recognise near-fatal asthma instantly, escalate without waiting for investigations, and then convert a life-threatening event into a structured secondary-prevention plan. They also want to see that you understand the physiology of ventilating a severely obstructed patient.

Liked those? The full pack has 14 scenarios at this standard - every one with a model answer.

Get the full pack - AED 699

What's inside

  • ✓14 original panel-style scenarios
  • ✓Model answer in all three graded domains
  • ✓Likely panel follow-up probes
  • ✓The pitfalls that fail candidates
  • ✓4+ ethics, consent and error-disclosure cases
  • ✓How each authority runs its oral

How the consultant Pulmonology oral is run, by authority

Consultant applicants who are not exempt are usually assessed by a panel rather than a computer exam. The format differs by authority.

AuthorityFormatLengthPanel and result
DHA - DubaiNot less than five clinical scenarios in your specialtyRoughly 20-30 minutesAt least two panellists, one pass or fail decision
DOH - Abu Dhabi5-6 case scenarios, including an ethical case45-60 minutesHeld on Microsoft Teams
SCFHS - Saudi ArabiaStructured consultant interview built on clinical casesTwo sessions of roughly 30 minutesSenior consultants in your specialty
OMSB - OmanViva on specialty cases, taken after the written examNot publishedRequired of every candidate

QCHP and NHRA assess most applicants by written exam and may add an interview or clinical assessment case by case. Your own eligibility notice is the final word on your route.

What a Pulmonology panel is assessing

Scenarios are judged across three domains: clinical knowledge, management, and ethics and communication. In Pulmonology, that looks like this:

  • •The panel is testing whether the candidate will act on a patient-safety concern despite social and political pressure, and whether they know the correct governance escalation route rather than resorting to informal or punitive responses.
  • •The panel is testing systematic pleural fluid interpretation, the decision pathway for an undiagnosed exudate, and recognition of unexpandable lung, which determines whether pleurodesis or an indwelling catheter is appropriate.
  • •The panel is testing emergency airway judgement in central airway obstruction, knowledge of interventional bronchoscopic options and their team requirements, and the ability to hold a goals-of-care discussion in an incurable disease at the same time as an emergency.

How to structure an oral answer

  1. 1Say what it is and why it is dangerous. Open with the working diagnosis, the one or two alternatives you must exclude, and what will harm the patient first.
  2. 2Show the knowledge that changes the decision. Name the finding, test or trial result your plan rests on. Panels mark reasoning, not recitation.
  3. 3Manage in time order. What you do in the next ten minutes, the next hour and the next day, who you escalate to, and what would make you change course.
  4. 4Close on ethics and communication. Consent or capacity, the family conversation, disclosure if something went wrong, and what you document. Every authority examines this domain.

Worked Pulmonology scenario outlines

4 original scenarios from the pack, written the way a panel would put them to you. Each outline shows the opening of the model answer in all three domains, the follow-up questions to expect and the mistakes that fail candidates.

Critical Care / Bronchiectasis and Airways

A 46-year-old man with post-tuberculous bronchiectasis and a right upper lobe cavity is admitted after coughing up approximately 500 mL of fresh blood over two hours, with continued bleeding on the ward. He is tachycardic at 120, blood pressure 96/60, saturation 88% on a non-rebreather mask, and is coughing frankly bloody secretions. Chest radiograph shows right upper zone opacification with a known cavity. His wife is at the bedside and is extremely distressed. How would you manage this patient?

What the panel is testing: The panel wants to see prioritisation of airway and lateralisation over diagnosis, knowledge of the definitive haemostatic pathway including bronchial artery embolisation, and the ability to communicate with a terrified family during an unstable resuscitation.

Show the answer outline

Knowledge: This is massive or life-threatening haemoptysis, and the immediate killer is asphyxiation from blood flooding the alveoli rather than exsanguination, so airway protection and control of soiling take precedence over identifying the bleeding source.

Management: I would call for help immediately, mobilising intensive care, interventional radiology and thoracic surgery in parallel, and move him to a resuscitation area with suction and a difficult airway trolley.

Ethics and communication: Consent for intubation and embolisation will have to be taken quickly and often in parallel with resuscitation; where the patient retains capacity I would give an honest but brief account of the risks, including spinal cord injury and rebleeding, and document that consent was obtained under emergency conditions, taking assent from his wife only where he cannot consent for himself.

Likely panel follow-up questions

  • Why is CT angiography preferred before bronchoscopy in a stable patient, and when would you reverse that order?
  • What are the complications of bronchial artery embolisation and how would you counsel the patient about them?
  • How would you achieve lung isolation if a double-lumen tube is not available?

Pitfalls in this case

  • Positioning the patient with the bleeding lung uppermost, allowing soiling of the good lung
  • Intubating with a small endotracheal tube that precludes therapeutic bronchoscopy
  • Sending an unstable patient for CT without an airway plan or escorting team

Reference: British Thoracic Society Guideline for Bronchiectasis in Adults (Thorax, 2019); Murray and Nadel's Textbook of Respiratory Medicine, 7th edition, 2022

Thoracic Oncology / Drug-Induced Lung Injury

A 64-year-old man with metastatic non-small cell lung cancer has had an excellent radiological response after four months of pembrolizumab. He now attends with two weeks of increasing breathlessness and dry cough, saturation 91% on air falling to 85% on walking, afebrile. CT shows new bilateral patchy ground-glass and organising-pneumonia-like opacities in areas away from his known tumour sites. He is desperate not to stop the drug that he says is keeping him alive. How would you manage him?

What the panel is testing: The panel is testing recognition and grading of an immune-related adverse event, the discipline of excluding infection and progression before immunosuppression, and a difficult shared decision about stopping an effective cancer therapy.

Show the answer outline

Knowledge: The most likely diagnosis is checkpoint inhibitor pneumonitis, an immune-related adverse event that occurs in around three to five percent of patients on anti-PD-1 monotherapy and more with combinations, typically within the first few months but potentially at any time, including after stopping the drug.

Management: I would admit him, give supplemental oxygen to maintain saturations above 92 percent, and simultaneously investigate and treat.

Ethics and communication: His plea not to stop the drug deserves a real conversation rather than a decree, so I would acknowledge how frightening it feels to stop something that has been working, then explain plainly that severe pneumonitis has a significant mortality and that continuing carries a substantial risk of him dying of the treatment rather than the cancer.

Likely panel follow-up questions

  • How do you grade checkpoint inhibitor pneumonitis and what does each grade mandate?
  • What must you exclude before attributing new infiltrates to immunotherapy, and how?
  • When and how do you escalate to second-line immunosuppression, and what agents would you choose?

Pitfalls in this case

  • Starting high-dose steroids without adequate sampling to exclude opportunistic infection
  • Under-grading a hypoxaemic patient as grade 2 and treating as an outpatient
  • Tapering corticosteroids too rapidly and precipitating relapse

Reference: ASCO Clinical Practice Guideline: Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy (J Clin Oncol, 2021 update); ESMO Clinical Practice Guideline on Management of Toxicities from Immunotherapy (Annals of Oncology, 2022)

End-of-Life Care in Advanced Lung Disease

A 74-year-old man with idiopathic pulmonary fibrosis, FVC 44% predicted, DLCO 28%, on 6 L/min oxygen at rest, has had three hospitalisations in four months and is now housebound and breathless washing himself. He is not a transplant candidate because of age and severe coronary disease. In clinic he says: 'Doctor, when the time comes I want you to do everything - I want the machine.' His wife privately tells you he is exhausted and has said he does not want to die in intensive care. How do you handle this consultation?

What the panel is testing: The panel is testing advance care planning skill in a progressive terminal illness, the handling of conflicting information from patient and family, and knowledge of evidence-based palliation of refractory breathlessness.

Show the answer outline

Knowledge: He has advanced idiopathic pulmonary fibrosis with physiology that places him in the highest mortality group, and with recurrent hospitalisation and severe functional limitation his median survival is likely measured in months.

Management: I would review him thoroughly first: repeat physiology, echocardiography to assess right ventricular pressure and left ventricular function, haemoglobin, screen for depression and for sleep-disordered breathing, review his antifibrotic tolerance and adherence, and check his oxygen prescription including ambulatory assessment and whether his home supply and equipment are adequate.

Ethics and communication: The heart of this consultation is understanding rather than persuading, so I would explore what doing everything means to him, ask what he is most worried about, and specifically ask whether his fear is of dying breathless, which I can address directly and truthfully by promising that we will not let him suffocate.

Likely panel follow-up questions

  • What is the outcome of invasive ventilation in advanced IPF, and how does that shape what you offer?
  • How do you use opioids for refractory breathlessness, and how do you answer a family who fear they will hasten death?
  • How do you handle information given to you privately by a spouse?

Pitfalls in this case

  • Accepting 'do everything' at face value without exploring what the patient means or fears
  • Presenting intubation as a neutral option in a disease where it is almost never successful
  • Withholding opioids for breathlessness through unfounded fear of respiratory depression

Reference: ATS/ERS/JRS/ALAT Clinical Practice Guideline on Idiopathic Pulmonary Fibrosis (Am J Respir Crit Care Med, 2022); ATS Official Clinical Policy Statement: Palliative Care for Patients with Respiratory Diseases and Critical Illnesses (Am J Respir Crit Care Med, 2008)

Sleep Medicine / Professional Duty and Public Safety

A 47-year-old man employed as a long-distance heavy goods vehicle driver in the UAE has a polysomnogram showing an apnoea-hypopnoea index of 62 per hour with a nadir saturation of 71%. His Epworth score is 17 and he admits to having nodded off at traffic lights twice and to one near-miss on the motorway last month. He tried CPAP for three nights, found it intolerable, and now refuses further therapy. He tells you that if you report him he will lose his livelihood and asks you to write that he is fit to drive. How do you handle this?

What the panel is testing: The panel is testing the balance between patient confidentiality and third-party safety, competence in CPAP adherence troubleshooting and alternative therapies, and the professional integrity to refuse to falsify a fitness certificate.

Show the answer outline

Knowledge: He has severe obstructive sleep apnoea with objectively documented excessive daytime sleepiness and, critically, sleepiness-related driving events, which together define the highest-risk group for motor vehicle collision; untreated severe OSA in a commercial driver raises crash risk several-fold and the near-miss is the single most important piece of history. The medical priority is to make effective treatment achievable rather than simply to record refusal, because most CPAP intolerance in the first week is fixable.

Management: I would tell him now, in the consultation, that with an AHI of 62, an Epworth of 17 and recent sleepiness-related events he should not drive a heavy goods vehicle until his condition is effectively treated, and I would record that advice verbatim.

Ethics and communication: I cannot write that he is fit to drive when he is not, and I would tell him so directly but without hostility: signing a false certificate would be fraud, would breach my registration conditions with the health authority, and could contribute to deaths.

Likely panel follow-up questions

  • What are the commonest reversible causes of early CPAP intolerance and how do you address each?
  • What objective criteria would you require before certifying him fit to resume commercial driving?
  • On what basis, and following what steps, would you breach confidentiality to inform the licensing authority?

Pitfalls in this case

  • Certifying fitness to drive under pressure, or issuing a deliberately vague letter to avoid conflict
  • Recording refusal of CPAP without any structured attempt to troubleshoot intolerance
  • Reporting to the authority without first informing the patient and offering him the chance to act

Reference: AASM Clinical Practice Guideline: Treatment of Adult Obstructive Sleep Apnea with Positive Airway Pressure (Journal of Clinical Sleep Medicine, 2019); ATS Clinical Practice Guideline: Sleep Apnea, Sleepiness and Driving Risk (Am J Respir Crit Care Med, 2013)

Common reasons candidates fail the Pulmonology oral

  • ✕Handling it informally with a quiet word and no documentation or escalation
  • ✕Accepting one negative cytology as excluding malignancy in an asbestos-exposed patient
  • ✕Sedating the patient or laying her flat, precipitating complete airway obstruction
  • ✕Attributing the pneumothorax to a recognised complication and not mentioning the absent ultrasound
  • ✕Delaying reperfusion to obtain a D-dimer or a formal risk score in a hypotensive patient
  • ✕Labelling any basal reticulation as IPF and starting an antifibrotic without a multidisciplinary diagnosis

Pulmonology oral syllabus

The clinical and professional areas the scenarios in this pack are drawn from:

  • COPD / Non-invasive Ventilation and Ceiling of Care
  • Critical Care / Bronchiectasis and Airways
  • End-of-Life Care in Advanced Lung Disease
  • Interstitial Lung Disease
  • Interventional Pulmonology / Thoracic Oncology
  • Obstructive Lung Disease / Critical Care
  • Occupational Lung Disease
  • Patient Safety / Disclosure of Error
  • Pleural Disease
  • Professionalism / Colleague Performance and Governance
  • Pulmonary Vascular Disease
  • Sleep Medicine / Professional Duty and Public Safety
  • Thoracic Oncology / Drug-Induced Lung Injury
  • Tuberculosis / Public Health Ethics

Panels expect specialist-level command of the written Pulmonology blueprint too, which covers:

  • Obstructive Lung Disease
  • Interstitial and Inflammatory (Diffuse Parenchymal) Lung Disease
  • Respiratory Infections and Tuberculosis
  • Sleep Medicine and Sleep-Disordered Breathing
  • Pulmonary Vascular Disorders
  • Thoracic Neoplasms and Lung Cancer
  • Pleural Diseases
  • Occupational and Environmental Lung Disease
  • Congenital, Neuromuscular, Chest Wall and Airway Structural Disorders
  • Critical Care Medicine and Respiratory Failure
  • Respiratory Physiology, Pulmonary Function Testing and Thoracic Imaging
  • Interventional Pulmonology, Bronchoscopy and Lung Transplantation
  • Patient Safety, Professionalism, Ethics and Communication

Sitting the written exam as well? Pulmonology question bank or the free Pulmonology mock exam.

Last reviewed September 2026

About these questions: every scenario and model answer is original, written for this pack, with a guideline or trial reference. No recalled or leaked exam content is used. How we write our questions.

Frequently asked questions

Are these real Consultant Pulmonology - Oral Assessment exam questions?
No. Every item is original, researched by Neelim's exam research team against the exam blueprint published by the health authorities. Real, recalled or leaked exam content breaches the testing bodies' rules and can lead to a permanent exam ban - we do not sell it, and neither should anyone else.
How is the oral assessment actually run?
It varies by authority. DHA requires not less than five clinical scenarios across roughly 20-30 minutes with a minimum of two panellists, scored pass or fail. DOH Abu Dhabi runs 5-6 scenarios including an ethical case over 45-60 minutes on Microsoft Teams. SCFHS uses a structured consultant interview of two roughly 30-minute case-based sessions, and OMSB requires a viva for every candidate after the written exam. The pack briefs you on each.
Does this cover DHA, DOH, MOHAP and SCFHS?
The core clinical knowledge is shared across the GCC; what differs by regulator is the test vendor (Prometric for DHA, SCFHS, QCHP, NHRA, Kuwait MOH; Pearson VUE for DOH, OMSB), the format, the pass mark and the local-regulation slice. The pack briefs you on how each authority runs its panel.
How do I receive it?
As PDF files. Card checkout is being set up, so for now you request it from this page and we send it to you directly, usually the same day.

Still unsure whether you even need this exam?

Your route depends on your profession, your licence title and the authority. We have guided over 1,000 professionals through GCC licensing - tell us your situation and we will confirm exactly what you need to sit.